APO Research
Talk to an analyst

APO RESEARCH · REPORT

Febrile Neutropenia

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Febrile Neutropenia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025183 pages

Choose your research edition.

Industry ResearchFebrile Neutropenia Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Febrile Neutropenia Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Febrile Neutropenia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Febrile Neutropenia Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Febrile Neutropenia Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Febrile Neutropenia market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Febrile Neutropenia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Febrile Neutropenia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Febrile Neutropenia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Febrile Neutropenia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Febrile Neutropenia include BeyondSpring Inc., Eli Lilly and Company, Taiho Pharmaceutical Co., Ltd., Amgen Inc., Xenetic Biosciences, Inc. (XBIO), USV Private Limited, Richter Gedeon Nyrt., Hospira, Inc. and Aequus BioPharma, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Febrile Neutropenia market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Febrile Neutropenia and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Febrile Neutropenia revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Febrile Neutropenia market size, projected growth trends, production technologies, key applications, and end-use industries.

Febrile Neutropenia Segment by Company

BeyondSpring Inc.

Eli Lilly and Company

Taiho Pharmaceutical Co., Ltd.

Amgen Inc.

Xenetic Biosciences, Inc. (XBIO)

USV Private Limited

Richter Gedeon Nyrt.

Hospira, Inc.

Aequus BioPharma, Inc.

Febrile Neutropenia Segment by Type

Filgrastim Biosimilars

Pegfilgrastim

Pegfilgrastim Biosimilars

Vancomycin Hydrochloride

Others

Febrile Neutropenia Segment by Application

Hospitals

Clinics

Others

Febrile Neutropenia Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Febrile Neutropenia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Febrile Neutropenia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Febrile Neutropenia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Febrile Neutropenia in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Febrile Neutropenia industry.

Chapter 3: Detailed analysis of Febrile Neutropenia companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Febrile Neutropeniarevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Febrile Neutropenia Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Filgrastim Biosimilars Table 3. Key Players of Pegfilgrastim Table 4. Key Players of Pegfilgrastim Biosimilars Table 3. Key Players of Vancomycin Hydrochloride Table 4. Key Players of Others Table 5. Global Febrile Neutropenia Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospitals Table 7. Key Players of Clinics Table 8. Key Players of Others Table 9. Global Febrile Neutropenia Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Febrile Neutropenia Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Febrile Neutropenia Market Share by Region (2021-2026) Table 12. Global Febrile Neutropenia Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Febrile Neutropenia Market Share by Region (2027-2032) Table 14. Febrile Neutropenia Industry Trends Table 15. Febrile Neutropenia Industry Drivers Table 16. Febrile Neutropenia Industry Opportunities and Challenges Table 17. Febrile Neutropenia Industry Restraints Table 18. Global Febrile Neutropenia Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Febrile Neutropenia Revenue Market Share by Company (2021-2026) Table 20. Global Febrile Neutropenia Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Febrile Neutropenia Key Company Head Office and Area Served Table 22. Global Febrile Neutropenia Company, Product Type & Application Table 23. Global Febrile Neutropenia Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Febrile Neutropenia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Febrile Neutropenia Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Febrile Neutropenia Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Febrile Neutropenia Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Febrile Neutropenia Revenue Market Share by Type (2021-2026) Table 30. Global Febrile Neutropenia Revenue Market Share by Type (2027-2032) Table 31. Global Febrile Neutropenia Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Febrile Neutropenia Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Febrile Neutropenia Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Febrile Neutropenia Revenue Market Share by Application (2021-2026) Table 35. Global Febrile Neutropenia Revenue Market Share by Application (2027-2032) Table 36. BeyondSpring Inc. Company Information Table 37. BeyondSpring Inc. Business Overview Table 38. BeyondSpring Inc. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. BeyondSpring Inc. Febrile Neutropenia Product Portfolio Table 40. BeyondSpring Inc. Recent Development Table 41. Eli Lilly and Company Company Information Table 42. Eli Lilly and Company Business Overview Table 43. Eli Lilly and Company Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Eli Lilly and Company Febrile Neutropenia Product Portfolio Table 45. Eli Lilly and Company Recent Development Table 46. Taiho Pharmaceutical Co., Ltd. Company Information Table 47. Taiho Pharmaceutical Co., Ltd. Business Overview Table 48. Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Product Portfolio Table 50. Taiho Pharmaceutical Co., Ltd. Recent Development Table 51. Amgen Inc. Company Information Table 52. Amgen Inc. Business Overview Table 53. Amgen Inc. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Amgen Inc. Febrile Neutropenia Product Portfolio Table 55. Amgen Inc. Recent Development Table 56. Xenetic Biosciences, Inc. (XBIO) Company Information Table 57. Xenetic Biosciences, Inc. (XBIO) Business Overview Table 58. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Product Portfolio Table 60. Xenetic Biosciences, Inc. (XBIO) Recent Development Table 61. USV Private Limited Company Information Table 62. USV Private Limited Business Overview Table 63. USV Private Limited Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. USV Private Limited Febrile Neutropenia Product Portfolio Table 65. USV Private Limited Recent Development Table 66. Richter Gedeon Nyrt. Company Information Table 67. Richter Gedeon Nyrt. Business Overview Table 68. Richter Gedeon Nyrt. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Richter Gedeon Nyrt. Febrile Neutropenia Product Portfolio Table 70. Richter Gedeon Nyrt. Recent Development Table 71. Hospira, Inc. Company Information Table 72. Hospira, Inc. Business Overview Table 73. Hospira, Inc. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Hospira, Inc. Febrile Neutropenia Product Portfolio Table 75. Hospira, Inc. Recent Development Table 76. Aequus BioPharma, Inc. Company Information Table 77. Aequus BioPharma, Inc. Business Overview Table 78. Aequus BioPharma, Inc. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Aequus BioPharma, Inc. Febrile Neutropenia Product Portfolio Table 80. Aequus BioPharma, Inc. Recent Development Table 81. North America Febrile Neutropenia Market Size by Type (2021-2026) & (US$ Million) Table 82. North America Febrile Neutropenia Market Size by Type (2027-2032) & (US$ Million) Table 83. North America Febrile Neutropenia Market Size by Application (2021-2026) & (US$ Million) Table 84. North America Febrile Neutropenia Market Size by Application (2027-2032) & (US$ Million) Table 85. North America Febrile Neutropenia Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Febrile Neutropenia Market Size by Country (2021-2026) Table 87. North America Febrile Neutropenia Market Size by Country (2027-2032) Table 88. Europe Febrile Neutropenia Market Size by Type (2021-2026) & (US$ Million) Table 89. Europe Febrile Neutropenia Market Size by Type (2027-2032) & (US$ Million) Table 90. Europe Febrile Neutropenia Market Size by Application (2021-2026) & (US$ Million) Table 91. Europe Febrile Neutropenia Market Size by Application (2027-2032) & (US$ Million) Table 92. Europe Febrile Neutropenia Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Febrile Neutropenia Market Size by Country (2021-2026) Table 94. Europe Febrile Neutropenia Market Size by Country (2027-2032) Table 95. China Febrile Neutropenia Market Size by Type (2021-2026) & (US$ Million) Table 96. China Febrile Neutropenia Market Size by Type (2027-2032) & (US$ Million) Table 97. China Febrile Neutropenia Market Size by Application (2021-2026) & (US$ Million) Table 98. China Febrile Neutropenia Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Febrile Neutropenia Market Size by Type (2021-2026) & (US$ Million) Table 100. Asia Febrile Neutropenia Market Size by Type (2027-2032) & (US$ Million) Table 101. Asia Febrile Neutropenia Market Size by Application (2021-2026) & (US$ Million) Table 102. Asia Febrile Neutropenia Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Febrile Neutropenia Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Febrile Neutropenia Market Size by Country (2021-2026) Table 105. Asia Febrile Neutropenia Market Size by Country (2027-2032) Table 106. South America, Middle East & Africa Febrile Neutropenia Market Size by Type (2021-2026) & (US$ Million) Table 107. South America, Middle East & Africa Febrile Neutropenia Market Size by Type (2027-2032) & (US$ Million) Table 108. South America, Middle East & Africa Febrile Neutropenia Market Size by Application (2021-2026) & (US$ Million) Table 109. South America, Middle East & Africa Febrile Neutropenia Market Size by Application (2027-2032) & (US$ Million) Table 110. South America, Middle East & Africa Febrile Neutropenia Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. South America, Middle East & Africa Febrile Neutropenia Market Size by Country (2021-2026) Table 112. South America, Middle East & Africa Febrile Neutropenia Market Size by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Febrile Neutropenia Product Image Figure 2. Global Febrile Neutropenia Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Febrile Neutropenia Market Share by Type: 2025 VS 2032 Figure 4. Filgrastim Biosimilars Image Figure 5. Pegfilgrastim Image Figure 6. Pegfilgrastim Biosimilars Image Figure 7. Vancomycin Hydrochloride Image Figure 8. Others Image Figure 9. Global Febrile Neutropenia Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Febrile Neutropenia Market Share by Application: 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Others Image Figure 14. Global Febrile Neutropenia Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 16. Global Febrile Neutropenia Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Febrile Neutropenia Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Febrile Neutropenia Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Febrile Neutropenia Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Febrile Neutropenia Revenue Market Share by Type (2021-2032) Figure 23. Global Febrile Neutropenia Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Febrile Neutropenia Revenue Market Share by Application (2021-2032) Figure 25. North America Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 26. North America Febrile Neutropenia Market Share by Type (2021-2032) Figure 27. North America Febrile Neutropenia Market Share by Application (2021-2032) Figure 28. North America Febrile Neutropenia Market Share by Country (2021-2032) Figure 29. United States Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 30. Canada Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 32. Europe Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 33. Europe Febrile Neutropenia Market Share by Type (2021-2032) Figure 34. Europe Febrile Neutropenia Market Share by Application (2021-2032) Figure 35. Europe Febrile Neutropenia Market Share by Country (2021-2032) Figure 36. Germany Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 37. France Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 39. Italy Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 40. Russia Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 42. China Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 43. China Febrile Neutropenia Market Share by Type (2021-2032) Figure 44. China Febrile Neutropenia Market Share by Application (2021-2032) Figure 45. Asia Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 46. Asia Febrile Neutropenia Market Share by Type (2021-2032) Figure 47. Asia Febrile Neutropenia Market Share by Application (2021-2032) Figure 48. Asia Febrile Neutropenia Market Share by Country (2021-2032) Figure 49. Japan Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 53. India Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 54. Australia Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Febrile Neutropenia Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Febrile Neutropenia Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Febrile Neutropenia Market Share by Country (2021-2032) Figure 59. Brazil Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 64. UAE Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 66. Chile Febrile Neutropenia Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Filgrastim Biosimilars
  • Pegfilgrastim
  • Pegfilgrastim Biosimilars
  • Vancomycin Hydrochloride
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • BeyondSpring Inc.
  • Eli Lilly and Company
  • Taiho Pharmaceutical Co., Ltd.
  • Amgen Inc.
  • Xenetic Biosciences, Inc. (XBIO)
  • USV Private Limited
  • Richter Gedeon Nyrt.
  • Hospira, Inc.
  • Aequus BioPharma, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Febrile Neutropenia Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Filgrastim Biosimilars
  5. 1.2.3 Pegfilgrastim
  6. 1.2.4 Pegfilgrastim Biosimilars
  7. 1.2.5 Vancomycin Hydrochloride
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Febrile Neutropenia Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Clinics
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Febrile Neutropenia Growth Trends by Region
  16. 1.5.1 Global Febrile Neutropenia Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Febrile Neutropenia Market Size by Region (2021-2026)
  18. 1.5.3 Febrile Neutropenia Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Febrile Neutropenia Market Dynamics
  1. 2.1 Febrile Neutropenia Industry Trends
  2. 2.2 Febrile Neutropenia Industry Drivers
  3. 2.3 Febrile Neutropenia Industry Opportunities and Challenges
  4. 2.4 Febrile Neutropenia Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Febrile Neutropenia Revenue by Company (2021-2026)
  2. 3.2 Global Febrile Neutropenia Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Febrile Neutropenia Key Company Head office and Area Served
  4. 3.4 Global Febrile Neutropenia Company, Product Type & Application
  5. 3.5 Global Febrile Neutropenia Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Febrile Neutropenia Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Febrile Neutropenia Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Febrile Neutropenia Tier 1, Tier 2, and Tier 3
4 Febrile Neutropenia Market by Type
  1. 4.1 Global Febrile Neutropenia Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Febrile Neutropenia Market Size by Type (2021-2032)
  3. 4.3 Global Febrile Neutropenia Market Size Share by Type (2021-2032)
5 Febrile Neutropenia Market by Application
  1. 5.1 Global Febrile Neutropenia Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Febrile Neutropenia Market Size by Application (2021-2032)
  3. 5.3 Global Febrile Neutropenia Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 BeyondSpring Inc.
  2. 6.1.1 BeyondSpring Inc. Company Information
  3. 6.1.2 BeyondSpring Inc. Business Overview
  4. 6.1.3 BeyondSpring Inc. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 BeyondSpring Inc. Febrile Neutropenia Product Portfolio
  6. 6.1.5 BeyondSpring Inc. Recent Developments
  7. 6.2 Eli Lilly and Company
  8. 6.2.1 Eli Lilly and Company Company Information
  9. 6.2.2 Eli Lilly and Company Business Overview
  10. 6.2.3 Eli Lilly and Company Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eli Lilly and Company Febrile Neutropenia Product Portfolio
  12. 6.2.5 Eli Lilly and Company Recent Developments
  13. 6.3 Taiho Pharmaceutical Co., Ltd.
  14. 6.3.1 Taiho Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Taiho Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Product Portfolio
  18. 6.3.5 Taiho Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Amgen Inc.
  20. 6.4.1 Amgen Inc. Company Information
  21. 6.4.2 Amgen Inc. Business Overview
  22. 6.4.3 Amgen Inc. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Amgen Inc. Febrile Neutropenia Product Portfolio
  24. 6.4.5 Amgen Inc. Recent Developments
  25. 6.5 Xenetic Biosciences, Inc. (XBIO)
  26. 6.5.1 Xenetic Biosciences, Inc. (XBIO) Company Information
  27. 6.5.2 Xenetic Biosciences, Inc. (XBIO) Business Overview
  28. 6.5.3 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Product Portfolio
  30. 6.5.5 Xenetic Biosciences, Inc. (XBIO) Recent Developments
  31. 6.6 USV Private Limited
  32. 6.6.1 USV Private Limited Company Information
  33. 6.6.2 USV Private Limited Business Overview
  34. 6.6.3 USV Private Limited Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 USV Private Limited Febrile Neutropenia Product Portfolio
  36. 6.6.5 USV Private Limited Recent Developments
  37. 6.7 Richter Gedeon Nyrt.
  38. 6.7.1 Richter Gedeon Nyrt. Company Information
  39. 6.7.2 Richter Gedeon Nyrt. Business Overview
  40. 6.7.3 Richter Gedeon Nyrt. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Richter Gedeon Nyrt. Febrile Neutropenia Product Portfolio
  42. 6.7.5 Richter Gedeon Nyrt. Recent Developments
  43. 6.8 Hospira, Inc.
  44. 6.8.1 Hospira, Inc. Company Information
  45. 6.8.2 Hospira, Inc. Business Overview
  46. 6.8.3 Hospira, Inc. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Hospira, Inc. Febrile Neutropenia Product Portfolio
  48. 6.8.5 Hospira, Inc. Recent Developments
  49. 6.9 Aequus BioPharma, Inc.
  50. 6.9.1 Aequus BioPharma, Inc. Company Information
  51. 6.9.2 Aequus BioPharma, Inc. Business Overview
  52. 6.9.3 Aequus BioPharma, Inc. Febrile Neutropenia Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Aequus BioPharma, Inc. Febrile Neutropenia Product Portfolio
  54. 6.9.5 Aequus BioPharma, Inc. Recent Developments
7 North America
  1. 7.1 North America Febrile Neutropenia Market Size (2021-2032)
  2. 7.2 North America Febrile Neutropenia Market Size by Type
  3. 7.2.1 North America Febrile Neutropenia Market Size by Type (2021-2026)
  4. 7.2.2 North America Febrile Neutropenia Market Size by Type (2027-2032)
  5. 7.2.3 North America Febrile Neutropenia Market Share by Type (2021-2032)
  6. 7.3 North America Febrile Neutropenia Market Size by Application
  7. 7.3.1 North America Febrile Neutropenia Market Size by Application (2021-2026)
  8. 7.3.2 North America Febrile Neutropenia Market Size by Application (2027-2032)
  9. 7.3.3 North America Febrile Neutropenia Market Share by Application (2021-2032)
  10. 7.4 North America Febrile Neutropenia Market Size by Country
  11. 7.4.1 North America Febrile Neutropenia Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Febrile Neutropenia Market Size by Country (2021-2026)
  13. 7.4.3 North America Febrile Neutropenia Market Size by Country (2027-2032)
  14. 7.4.4 North America Febrile Neutropenia Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Febrile Neutropenia Market Size (2021-2032)
  2. 8.2 Europe Febrile Neutropenia Market Size by Type
  3. 8.2.1 Europe Febrile Neutropenia Market Size by Type (2021-2026)
  4. 8.2.2 Europe Febrile Neutropenia Market Size by Type (2027-2032)
  5. 8.2.3 Europe Febrile Neutropenia Market Share by Type (2021-2032)
  6. 8.3 Europe Febrile Neutropenia Market Size by Application
  7. 8.3.1 Europe Febrile Neutropenia Market Size by Application (2021-2026)
  8. 8.3.2 Europe Febrile Neutropenia Market Size by Application (2027-2032)
  9. 8.3.3 Europe Febrile Neutropenia Market Share by Application (2021-2032)
  10. 8.4 Europe Febrile Neutropenia Market Size by Country
  11. 8.4.1 Europe Febrile Neutropenia Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Febrile Neutropenia Market Size by Country (2021-2026)
  13. 8.4.3 Europe Febrile Neutropenia Market Size by Country (2027-2032)
  14. 8.4.4 Europe Febrile Neutropenia Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Febrile Neutropenia Market Size (2021-2032)
  2. 9.2 China Febrile Neutropenia Market Size by Type
  3. 9.2.1 China Febrile Neutropenia Market Size by Type (2021-2026)
  4. 9.2.2 China Febrile Neutropenia Market Size by Type (2027-2032)
  5. 9.2.3 China Febrile Neutropenia Market Share by Type (2021-2032)
  6. 9.3 China Febrile Neutropenia Market Size by Application
  7. 9.3.1 China Febrile Neutropenia Market Size by Application (2021-2026)
  8. 9.3.2 China Febrile Neutropenia Market Size by Application (2027-2032)
  9. 9.3.3 China Febrile Neutropenia Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Febrile Neutropenia Market Size (2021-2032)
  2. 10.2 Asia Febrile Neutropenia Market Size by Type
  3. 10.2.1 Asia Febrile Neutropenia Market Size by Type (2021-2026)
  4. 10.2.2 Asia Febrile Neutropenia Market Size by Type (2027-2032)
  5. 10.2.3 Asia Febrile Neutropenia Market Share by Type (2021-2032)
  6. 10.3 Asia Febrile Neutropenia Market Size by Application
  7. 10.3.1 Asia Febrile Neutropenia Market Size by Application (2021-2026)
  8. 10.3.2 Asia Febrile Neutropenia Market Size by Application (2027-2032)
  9. 10.3.3 Asia Febrile Neutropenia Market Share by Application (2021-2032)
  10. 10.4 Asia Febrile Neutropenia Market Size by Country
  11. 10.4.1 Asia Febrile Neutropenia Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Febrile Neutropenia Market Size by Country (2021-2026)
  13. 10.4.3 Asia Febrile Neutropenia Market Size by Country (2027-2032)
  14. 10.4.4 Asia Febrile Neutropenia Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Febrile Neutropenia Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Febrile Neutropenia Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Febrile Neutropenia Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Febrile Neutropenia Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Febrile Neutropenia Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Febrile Neutropenia Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Febrile Neutropenia Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Febrile Neutropenia Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Febrile Neutropenia Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Febrile Neutropenia Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Febrile Neutropenia Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Febrile Neutropenia Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Febrile Neutropenia Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Febrile Neutropenia Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst